Total Income is Rs.42065.90 mn for the quarter ended March 31, 2016 where as the same was at Rs.30953.50 million for the quarter ended March 31, 2015.
Lupin posted a net profit after taxes and minority interest of Rs. 8070.80 mn for the quarter ended March 31, 2016 where as the same was at Rs. 5470.10 mn for the quarter ended March 31, 2015.
Total Income is Rs. 42065.90 mn for the quarter ended March 31, 2016 where as the same was at Rs. 30953.50 million for the quarter ended March 31, 2015.
The Group has posted a net profit after taxes and minority interest of Rs. 22706.90 million for the year ended March 31, 2016 where as the same was at Rs. 24032.40 mn for the year ended March 31, 2015.
Total Income is Rs. 143961.70 mn for the year ended March 31, 2016 where as the same was at Rs. 130097.60 million for the year ended March 31, 2015.
EBITDA margin of the pharma major stood at 32.7%.
Lupin Ltd is currently trading at Rs. 1663.1, up by Rs. 30.65 or 1.88% from its previous closing of Rs. 1632.45 on the BSE.EBITDA margin of the pharma major stood at 32.7%.
The Board of Directors of the Company at its meeting held on May 19, 2016, recommended dividend @ 375% i.e. Rs. 7.50 per equity share of the face value of Rs. 2/- each for the year ended March 31, 2016, subject to approval of the members at the ensuing Annual General Meeting.
The scrip opened at Rs. 1650 and has touched a high and low of Rs. 1679 and Rs. 1643.5 respectively. So far 1671001(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 73574 crore.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 2127 on 06-Oct-2015 and a 52 week low of Rs. 1294.05 on 29-Mar-2016. Last one week high and low of the scrip stood at Rs. 1646 and Rs. 1572.6 respectively.
The promoters holding in the company stood at 46.52 % while Institutions and Non-Institutions held 42.27 % and 11.22 % respectively.
The stock is currently trading above its 200 DMA.
No comments:
Post a Comment